Primary Record
Favipiravir
- In stock
- 5,572 g
- Purity
- 99.0 %
- CAS
- 259793-96-9
Compound Identifiers & Properties
- CAS
- 259793-96-9
- PubChem CID
- 492405
- SMILES
- C1=C(N=C(C(=O)N1)C(=O)N)F
- Canonical SMILES
- NC(=O)c1nc(F)c[nH]c1=O
Names & Synonyms
- Favipiravir
- avigan
- 259793-96-9
- Fapilavir
- Favilavir
- favipiravirum
- Avipiravir
- Crebinostat
- 6-FLUORO-3-HYDROXYPYRAZINE-2-CARBOXAMIDE
- FabiFlu
- T-705
- pyrazinecarboxamide
- Favipiravir [INN]
- Favipiravir (T-705)
- 5-fluoro-2-oxo-1H-pyrazine-3-carboxamide
- Avigan (TN)
- Favipiravir; T-705
- 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
- 6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide
- Favipiravir/T-705
- T-705 cpd
- AC1LAOUM
- EW5GL2X7E0
- Favipiravir (Standard)
- RefChem:6434
- UNII-EW5GL2X7E0
- FAVIPIRAVIR [MI]
- FAVIPIRAVIR [JAN]
- C5H4FN3O2
- FAVIPIRAVIR [USAN]
- Favipiravir (T-705)?
- T 705
- Favipiravir [USAN:INN:JAN]
- FAVIPIRAVIR [WHO-DD]
- cc-562
- SCHEMBL587913
- CHEBI:134722
- DTXSID60948878
- 6-fluoro-3-hydroxy-pyrazine-2-carboxamide
- Favipiravir (JAN/USAN/INN)
- MFCD12032148
- AMPZ0004
- CHEMBL221722
- orb1300424
- SCHEMBL6378032
- T705
- CTK8C4699
- GTPL11139
- AOB2076
- J05AX27
- ZCGNOVWYSGBHAU-UHFFFAOYSA-N
- 2-Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo-
- AIDS121660
- BCPP000056
- DTXCID701377091
- GLXC-04705
- HMS5086M03
- BCP02422
- EX-A2285
- 2-Pyrazinecarboxamide, 6-fluoro-3-hydroxy-
- ANW-72832
- BBF-05847
- BBL104098
- CF0036
- CID492405
- EBC-06186
- HY-14768R
- MFCD16879084
- MSK160867
- Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo-
- QC-771
- RW3035
- s7975
- STL557913
- ZINC13915654
- AKOS005166863
- AKOS015995178
- ZINC584639712
- ZINC584639713
- ACN-041491
- AN-1700
- CCG-266269
- CID:492405
- CS-0612
- DB12466
- FF29069
- PB25591
- PB42412
- RP22092
- 6-fluoro-3,4-dihydro-3-oxo-Pyrazinecarboxamide
- 6-Fluoro-3-hydropyrazine-2-carboxamide
- NCGC00373041-03
- NCGC00373041-06
- 3-Hydroxy-6-fluoropyrazine-2-carboxamide
- AC-28900
- AK-67681
- BR-67681
- DA-19682
- HY-14768
- MS-20791
- SC-43861
- SY110833
- 6-fluoro-3-hydroxy-2-pyrazine carboxamide
- 6-fluoro-3-hydroxypyrazine-2-carbo xamide
- 6-fluoro-3-oxo-4H-pyrazine-2-carboxamide
- SID:406166238
- ST1120855
- AM20080851
- B1114
- FT-0686297
- FT-0701282
- NS00071016
- 6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide
- J1.636.682J
- A11590
- A25520
- D09537
- S-7880
- EN300-1601539
- 793P969
- A902150
- C462182
- F079875
- Pyrazinecarboxamide,6-fluoro-3,4-dihydro-3-oxo-
- 2-Pyrazinecarboxamide,6-fluoro-3,4-dihydro-3-oxo-
- 5-Fluoro-2-oxo-1H-pyrazine-3-carboxamide, 95+%
- T 705,CAS;259793-96-9
- BRD-K04264130-001-01-4
- Q16934561
- Z1255381648
- B0084-463609
- 1092061-61-4
- 6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide; 6-Fluoro-3,4-dihydro-3-oxo-pyrazinecarboxamide; 6-Fluoro-3-hydroxy-2-pyrazinecarboxamide; Favipiravir; T 705; T 705 (Pharmaceutical)
- 856-840-0
- FPV
- N/A